Medical

TSX: IN OTCQX: IMLFF VANCOUVER, March 18, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical...

INVO Bioscience Launches Embryology Center in the Bay Area to Support Dedicated INVOcell Clinic Being Developed by Dr. Aimee, the “Egg Whisperer”

271

MEDFORD, Mass. and SAN FRANCISCO, March 12, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTC: IVOB), developers of the INVOcell intravaginal culture...

Cannabis Watch: Aurora Cannabis leads sector after stock is named Top Pick at Cowen

224

Cannabis shares were mostly higher Tuesday, with Aurora Cannabis Inc. a standout, after Cowen designated the stock its Top Pick...

Lifeline Biotechnologies Updates Shareholders and The Public

218

Reported by OTC Markets. We are pleased to share current information and developments with our stakeholders and the public, February...

GeoVax to Develop Vaccine Against Zika Virus

GeoVax Comments on Recent Vaccine Development Study Funded by the Gates Foundation

176

Research Article Describes Inadequate Funding Levels for Vaccines Against HIV, Malaria and Tuberculosis ATLANTA, GA, Sept. 19, 2018 (GLOBE NEWSWIRE) --...

Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

176

MINNEAPOLIS, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying...

Attis Completes Strategic Investment in Noveda Technologies

Energy

Attis Industries Executes Purchase Agreement to Acquire Custom Cable Services, Inc.

293

Attis Infrastructure Transaction to Consolidate 5G Infrastructure Companies MILTON, GA, Sept. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Attis...

Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5

161

FRAMINGHAM, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of liquid,...

Immune Therapeutics Labeled as a Pioneer in Forbes Article Discussing Booming Pet Care Industry

145

ORLANDO, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE - - Immune Therapeutics, Inc. (OTCQB: IMUN), a...

Renown HIV specialist Dr. Gary Blick Joins Immune Therapeutics Advisory Board

136

ORLANDO, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune Therapeutics", "IMUN" or...

Precision Therapeutics Reports Second Quarter 2018 Financial Results

141

Helomics Holding Corporation, predicted to generate approximately $3.2 million in revenues by the end of 2018 MINNEAPOLIS, Aug. 14, 2018...

General

eWellness is Developing a Tokenized Telehealth Payment System for the Healthcare Insurance Industry Update

136

Culver City, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the...

Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

134

MINNEAPOLIS, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial...

General

Immune Therapeutics Adds Former United States Assistant Surgeon General Dr. Roscoe Moore to Board of Directors

149

ORLANDO, Fla., Aug. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--Immune Therapeutics, Inc. (OTC: IMUN) (IMUN) ("Immune" “IMUN” or...

HedgePath Pharmaceuticals Announces Positive FDA Feedback from FDA Type-C Meeting and Files Pre-NDA Meeting Request

133

FDA has confirmed HPPI's clinical and regulatory pathway for SUBA BCCNS and provided further guidance for anticipated NDA submission PR...

Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange

142

MINNEAPOLIS, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial...

Progressive Care Reports $1.7 Million in Revenues in July

General

Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is a Safe and Credible Online Health Resource

141

MIAMI, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that...

Immune Therapeutics Inc Announces Publication of Peer Reviewed Scientific Paper Describing Low-Dose Naltrexone (LDN): A Promising Treatment in Immune-Related Diseases and Cancer Therapies

by Jayde Castillo

150

ORLANDO, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune" “IMUN” or the...

Research on Lodonal for HIV related GI complications featured in Plus Magazine

by Jayde Castillo

139

ORLANDO, Fla., July 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune" “IMUN” or the...

Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies

by Jayde Castillo